Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review (Q37505895)

20 August 2017

1 reference

title

Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review (English)

1 reference

20 August 2017

1 reference

0 references

Andrea Riner

1

1 reference

20 August 2017

Kirk M Chan-Tack

series ordinal

2

1 reference

20 August 2017

Jeffrey S Murray

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

20 August 2017

published in

Postgraduate Medicine

1 reference

20 August 2017

volume

121

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

139-146

1 reference

Mechanisms of action of ribavirin against distinct viruses

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Viral lower urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Children Hospitalized With Severe Acute Respiratory Syndrome-Related Illness in Toronto

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

A comparative study of clinical features and outcomes in young and older adults with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Short-term outcome of critically ill patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Adenovirus infection after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Parainfluenza virus type 3 infections in a hematology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Hemodialysis clearance of intravenously administered ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Adenovirus infections in adult recipients of blood and marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Lassa fever. Effective therapy with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Identification of severe acute respiratory syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Pregnancy outcome after exposure to injectable ribavirin during embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Infants born to mothers with severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Intravenous ribavirin therapy for adenovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

A Young Infant With Severe Acute Respiratory Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Severe acute respiratory syndrome in haemodialysis patients: a report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Failure of interferon alfa and tribavirin in rabies encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Survival after treatment of rabies with induction of coma

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.05.2014

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.05.2014

1 reference

20 August 2017

1 reference